Beyond Reprints for Scientific Information on Unapproved Uses of Medical Products | King & Spalding
Revised Draft FDA Guidance Expands Scope of Permissible Proactive Off-Label Communications This week, FDA published new revised draft guidance, Communications From Firms...
Source: jdsupra.com